Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (721-730 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|October 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapyOrla McCourt, Paul Maciocia, Claire Roddie, et al.
Ejhaem|October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocolNeil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Ejhaem|October 17, 2024
Routine hemostasis profile in steady state sickle cell disease adult patients compared to laboratory values, between phenotypes and during pregnancy: A retrospective, descriptive studyComlan Affo, Carine Schmidt, Antoine Bosquet, et al.
Ejhaem|October 17, 2024
Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipientsGary L Simmons, Roy Sabo, Rehan Qayyum, et al.
Ejhaem|October 17, 2024
Antiphospholipid syndrome, monoclonal gammopathy, and cryoglobulinemia overlap leading to recurrent cutaneous microvascular thrombosis: A case report and retrospective cohort studyAlexandra Bohm, Bo Angela Wan, Amir Karin, et al.
Ejhaem|February 21, 2025
Cutaneous Langerhans cell histiocytosis and other systemic inflammatory or autoimmune disease manifestations in the setting of clonal hematopoiesisGiby V George, Jane Liesveld, Siba El Hussein, et al.
Ejhaem|February 7, 2025
The prognostic value of POD24 in relapsed/refractory follicular lymphoma-A SCHOLAR-5 analysisEve H Limbrick-Oldfield, Steve Kanters, Markqayne D Ray, et al.
Ejhaem|August 19, 2024
Incidence and prevention of skeletal-related events in multiple myeloma patients: A population-based real-world experienceMarie Røra, Margrete Skretting Solberg, Kari Lenita Falck Moore, et al.
Ejhaem|August 19, 2024
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemiaAlexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, et al.
Ejhaem|August 19, 2024
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myelomaMaria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, et al.
Pageof 93

Showing results (721-730 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|October 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapyOrla McCourt, Paul Maciocia, Claire Roddie, et al.
Ejhaem|October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocolNeil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Ejhaem|October 17, 2024
Routine hemostasis profile in steady state sickle cell disease adult patients compared to laboratory values, between phenotypes and during pregnancy: A retrospective, descriptive studyComlan Affo, Carine Schmidt, Antoine Bosquet, et al.
Ejhaem|October 17, 2024
Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipientsGary L Simmons, Roy Sabo, Rehan Qayyum, et al.
Ejhaem|October 17, 2024
Antiphospholipid syndrome, monoclonal gammopathy, and cryoglobulinemia overlap leading to recurrent cutaneous microvascular thrombosis: A case report and retrospective cohort studyAlexandra Bohm, Bo Angela Wan, Amir Karin, et al.
Ejhaem|February 21, 2025
Cutaneous Langerhans cell histiocytosis and other systemic inflammatory or autoimmune disease manifestations in the setting of clonal hematopoiesisGiby V George, Jane Liesveld, Siba El Hussein, et al.
Ejhaem|February 7, 2025
The prognostic value of POD24 in relapsed/refractory follicular lymphoma-A SCHOLAR-5 analysisEve H Limbrick-Oldfield, Steve Kanters, Markqayne D Ray, et al.
Ejhaem|August 19, 2024
Incidence and prevention of skeletal-related events in multiple myeloma patients: A population-based real-world experienceMarie Røra, Margrete Skretting Solberg, Kari Lenita Falck Moore, et al.
Ejhaem|August 19, 2024
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemiaAlexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, et al.
Ejhaem|August 19, 2024
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myelomaMaria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, et al.
Pageof 93